Literature DB >> 24715120

Ten years of the national genetic diabetes nurse network: a model for the translation of genetic information into clinical care.

M Shepherd1, K Colclough, S Ellard, A T Hattersley.   

Abstract

Increasing technological advances have resulted in the recognition of a range of genetic conditions not traditionally seen by clinical genetics teams. This has implications for the education of other healthcare professionals who may have insufficient knowledge to identify or support families with these conditions. The national genetic diabetes nurse (GDN) project, which trains diabetes specialist nurses (DSNs), was started in 2002 to increase awareness of monogenic diabetes among healthcare professionals across the UK. This paper describes the development and evaluation of the first 10 years of this project, indicating that GDNs have increased diagnostic referral rates and supported local families through diagnosis and treatment changes across the UK. The GDN project has proved an effective, innovative means of disseminating new genetic information from a centre of excellence and is suggested as a model for the successful and rapid dissemination of genetic information into routine clinical care in other conditions.

Entities:  

Keywords:  Genetic diabetes nurses; maturity-onset diabetes of the young (MODY); monogenic diabetes; service provision

Mesh:

Year:  2014        PMID: 24715120      PMCID: PMC4953280          DOI: 10.7861/clinmedicine.14-2-117

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  9 in total

1.  No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas.

Authors:  Maggie Shepherd; Ewan R Pearson; Jane Houghton; Gill Salt; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 2.  Mainstreaming genetics: a comparative review of clinical services for inherited cardiovascular conditions in the UK.

Authors:  Hilary Burton; C Alberg; A Stewart
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

3.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

4.  A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England.

Authors:  Catherine L Bennett; Sarah E Burke; Hilary Burton; Peter A Farndon
Journal:  BMC Health Serv Res       Date:  2010-05-14       Impact factor: 2.655

5.  A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients.

Authors:  M Shepherd; B Shields; S Ellard; O Rubio-Cabezas; A T Hattersley
Journal:  Diabet Med       Date:  2009-04       Impact factor: 4.359

6.  Genetic cause of hyperglycaemia and response to treatment in diabetes.

Authors:  Ewan R Pearson; Bryan J Starkey; Roy J Powell; Fiona M Gribble; Penny M Clark; Andrew T Hattersley
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

7.  Genetics education for health professionals: strategies and outcomes from a national initiative in the United Kingdom.

Authors:  Peter A Farndon; Catherine Bennett
Journal:  J Genet Couns       Date:  2008-02-05       Impact factor: 2.537

8.  Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project.

Authors:  S G Hadfield; S Horara; B J Starr; S Yazdgerdi; D Marks; D Bhatnagar; R Cramb; S Egan; R Everdell; G Ferns; A Jones; C B Marenah; J Marples; P Prinsloo; A Sneyd; M F Stewart; L Sandle; T Wang; M S Watson; S E Humphries
Journal:  Ann Clin Biochem       Date:  2008-11-21       Impact factor: 2.057

9.  GPs have key role in detecting familial hypercholesterolaemia.

Authors:  Steve Humphries; Kristina Pedersen
Journal:  Practitioner       Date:  2011-02
  9 in total
  5 in total

1.  Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.

Authors:  Yue Guan; Kristin A Maloney; Toni I Pollin
Journal:  J Genet Couns       Date:  2020-03-12       Impact factor: 2.537

2.  Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Wendy K Chung; Karel Erion; Jose C Florez; Andrew T Hattersley; Marie-France Hivert; Christine G Lee; Mark I McCarthy; John J Nolan; Jill M Norris; Ewan R Pearson; Louis Philipson; Allison T McElvaine; William T Cefalu; Stephen S Rich; Paul W Franks
Journal:  Diabetologia       Date:  2020-09       Impact factor: 10.122

3.  Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.

Authors:  Lewis Pang; Kevin C Colclough; Maggie H Shepherd; Joanne McLean; Ewan R Pearson; Sian Ellard; Andrew T Hattersley; Beverley M Shields
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

Review 4.  How do I diagnose Maturity Onset Diabetes of the Young in my patients?

Authors:  Kevin Colclough; Kashyap Patel
Journal:  Clin Endocrinol (Oxf)       Date:  2022-05-02       Impact factor: 3.523

Review 5.  Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  Matthew C Riddle; Louis H Philipson; Stephen S Rich; Annelie Carlsson; Paul W Franks; Siri Atma W Greeley; John J Nolan; Ewan R Pearson; Philip S Zeitler; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2020-12       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.